Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7466201
[patent_doc_number] => 20040198682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => new
[patent_app_number] => 10/683990
[patent_app_country] => US
[patent_app_date] => 2003-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 57802
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198682.pdf
[firstpage_image] =>[orig_patent_app_number] => 10683990
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/683990 | RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA) | Oct 9, 2003 | Abandoned |
Array
(
[id] => 7133460
[patent_doc_number] => 20040043007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Transfection system'
[patent_app_type] => new
[patent_app_number] => 10/296087
[patent_app_country] => US
[patent_app_date] => 2003-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6868
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043007.pdf
[firstpage_image] =>[orig_patent_app_number] => 10296087
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/296087 | Transfection system | Sep 17, 2003 | Abandoned |
Array
(
[id] => 7530254
[patent_doc_number] => 07842476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-30
[patent_title] => 'In vitro peptide expression library'
[patent_app_type] => utility
[patent_app_number] => 10/526479
[patent_app_country] => US
[patent_app_date] => 2003-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 19599
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/842/07842476.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526479
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526479 | In vitro peptide expression library | Sep 4, 2003 | Issued |
Array
(
[id] => 7275548
[patent_doc_number] => 20040234999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Genetic suppression and replacement'
[patent_app_type] => new
[patent_app_number] => 10/651754
[patent_app_country] => US
[patent_app_date] => 2003-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 37654
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20040234999.pdf
[firstpage_image] =>[orig_patent_app_number] => 10651754
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/651754 | Genetic suppression and replacement | Aug 28, 2003 | Abandoned |
Array
(
[id] => 7403712
[patent_doc_number] => 20040023914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Antisense modulation of apaf-1 expression'
[patent_app_type] => new
[patent_app_number] => 10/399214
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26122
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023914.pdf
[firstpage_image] =>[orig_patent_app_number] => 10399214
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/399214 | Antisense modulation of apaf-1 expression | Aug 24, 2003 | Abandoned |
Array
(
[id] => 7314209
[patent_doc_number] => 20040033967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Alkylated hexitol nucleoside analogues and oligomers thereof'
[patent_app_type] => new
[patent_app_number] => 10/362660
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18931
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033967.pdf
[firstpage_image] =>[orig_patent_app_number] => 10362660
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/362660 | Alkylated hexitol nucleoside analogues and oligomers thereof | Aug 17, 2003 | Abandoned |
Array
(
[id] => 7603379
[patent_doc_number] => 07235653
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-26
[patent_title] => 'Oligonucleotide compositions and methods for the modulation of the expression of B7 protein'
[patent_app_type] => utility
[patent_app_number] => 10/641962
[patent_app_country] => US
[patent_app_date] => 2003-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 46721
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/235/07235653.pdf
[firstpage_image] =>[orig_patent_app_number] => 10641962
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/641962 | Oligonucleotide compositions and methods for the modulation of the expression of B7 protein | Aug 14, 2003 | Issued |
Array
(
[id] => 7033559
[patent_doc_number] => 20050032068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Sugar and backbone-surrogate-containing oligomeric compounds and compositions for use in gene modulation'
[patent_app_type] => utility
[patent_app_number] => 10/634483
[patent_app_country] => US
[patent_app_date] => 2003-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34396
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032068.pdf
[firstpage_image] =>[orig_patent_app_number] => 10634483
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/634483 | Sugar and backbone-surrogate-containing oligomeric compounds and compositions for use in gene modulation | Aug 4, 2003 | Abandoned |
Array
(
[id] => 7033558
[patent_doc_number] => 20050032067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Non-phosphorous-linked oligomeric compounds and their use in gene modulation'
[patent_app_type] => utility
[patent_app_number] => 10/634320
[patent_app_country] => US
[patent_app_date] => 2003-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32277
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032067.pdf
[firstpage_image] =>[orig_patent_app_number] => 10634320
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/634320 | Non-phosphorous-linked oligomeric compounds and their use in gene modulation | Aug 4, 2003 | Abandoned |
Array
(
[id] => 7394398
[patent_doc_number] => 20040038392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Expression vector enabling screening of cells with high expression of recombinant protein, transformant with high expression of recombinant protein and utilization thereof'
[patent_app_type] => new
[patent_app_number] => 10/297473
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13855
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038392.pdf
[firstpage_image] =>[orig_patent_app_number] => 10297473
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/297473 | Expression vector enabling screening of cells with high expression of recombinant protein, transformant with high expression of recombinant protein and utilization thereof | Jul 20, 2003 | Abandoned |
Array
(
[id] => 5771606
[patent_doc_number] => 20050267057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Immunostimulatory nucleic acid molecules'
[patent_app_type] => utility
[patent_app_number] => 10/619279
[patent_app_country] => US
[patent_app_date] => 2003-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 27142
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267057.pdf
[firstpage_image] =>[orig_patent_app_number] => 10619279
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/619279 | Immunostimulatory nucleic acid molecules | Jul 13, 2003 | Issued |
Array
(
[id] => 5875923
[patent_doc_number] => 20060167227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Truncated tau proteins'
[patent_app_type] => utility
[patent_app_number] => 10/521140
[patent_app_country] => US
[patent_app_date] => 2003-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 23515
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20060167227.pdf
[firstpage_image] =>[orig_patent_app_number] => 10521140
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/521140 | Truncated tau proteins | Jul 8, 2003 | Abandoned |
Array
(
[id] => 7460674
[patent_doc_number] => 20040052840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Preparations for oligonucleotide transfer'
[patent_app_type] => new
[patent_app_number] => 10/311621
[patent_app_country] => US
[patent_app_date] => 2003-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 13918
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20040052840.pdf
[firstpage_image] =>[orig_patent_app_number] => 10311621
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/311621 | Preparations for oligonucleotide transfer | Jun 22, 2003 | Abandoned |
Array
(
[id] => 7475830
[patent_doc_number] => 20040097990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Graft material, device & method of making'
[patent_app_type] => new
[patent_app_number] => 10/600364
[patent_app_country] => US
[patent_app_date] => 2003-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3257
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097990.pdf
[firstpage_image] =>[orig_patent_app_number] => 10600364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/600364 | Graft material, device & method of making | Jun 20, 2003 | Abandoned |
Array
(
[id] => 7393367
[patent_doc_number] => 20040038274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Gapped 2\' modified oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/601242
[patent_app_country] => US
[patent_app_date] => 2003-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13992
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038274.pdf
[firstpage_image] =>[orig_patent_app_number] => 10601242
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/601242 | Gapped 2' modified oligonucleotides | Jun 19, 2003 | Abandoned |
Array
(
[id] => 7674678
[patent_doc_number] => 20040127440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Methods and compositions for control of bone formation via modulation of neuropeptide Y activity'
[patent_app_type] => new
[patent_app_number] => 10/465910
[patent_app_country] => US
[patent_app_date] => 2003-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 32001
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127440.pdf
[firstpage_image] =>[orig_patent_app_number] => 10465910
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/465910 | Methods and compositions for control of bone formation via modulation of neuropeptide Y activity | Jun 16, 2003 | Abandoned |
Array
(
[id] => 7469137
[patent_doc_number] => 20040102406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Antisense oligonucleotides to inhibit angiogenesis and/or metastasis'
[patent_app_type] => new
[patent_app_number] => 10/312752
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8033
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102406.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312752
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312752 | Antisense oligonucleotides to inhibit angiogenesis and/or metastasis | Jun 11, 2003 | Abandoned |
Array
(
[id] => 7224759
[patent_doc_number] => 20040072783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Nucleozymes with endonuclease activity'
[patent_app_type] => new
[patent_app_number] => 10/457039
[patent_app_country] => US
[patent_app_date] => 2003-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15748
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072783.pdf
[firstpage_image] =>[orig_patent_app_number] => 10457039
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/457039 | Nucleozymes with endonuclease activity | Jun 5, 2003 | Abandoned |
Array
(
[id] => 7357957
[patent_doc_number] => 20040014055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Gene coding for erbin, and diagnostic and therapeutic uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/240926
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10764
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014055.pdf
[firstpage_image] =>[orig_patent_app_number] => 10240926
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/240926 | Gene coding for erbin, and diagnostic and therapeutic uses thereof | Jun 4, 2003 | Abandoned |
Array
(
[id] => 6635366
[patent_doc_number] => 20030211611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Antisense modulation of estrogen receptor alpha expression'
[patent_app_type] => new
[patent_app_number] => 10/448753
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27671
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211611.pdf
[firstpage_image] =>[orig_patent_app_number] => 10448753
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/448753 | Antisense modulation of estrogen receptor alpha expression | May 29, 2003 | Abandoned |